Connor Wells

Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).

Shaan Dudani, Guillermo de Velasco, Connor Wells et al. · Journal of Clinical Oncology · 2020 · 31 citations

Medicine, Biostatistics, Oncology +12

Cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (ICI) or targeted therapy (TT): A propensity score-based analysis.

Ziad Bakouny, Wanling Xie, Shaan Dudani et al. · Journal of Clinical Oncology · 2020 · 20 citations

Medicine, Biostatistics, Oncology +17

External validation of the International Metastatic Renal Cell Carcinoma (mRCC) Database Consortium prognostic model and comparison to four other models in the era of targeted therapy.

D.Y.C. Heng, Wanling Xie, Lauren C. Harshman et al. · Journal of Clinical Oncology · 2011 · 17 citations

Medicine, Biostatistics, Oncology +16

Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge

Elizabeth Nally, Matthew R. Young, Vishwani Chauhan et al. · Cancer Management and Research · 2024 · 14 citations · Full text

Medicine, Oncology, Urology +17

The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).

Andrew Schmidt, Wanling Xie, Chun Loo Gan et al. · Journal of Clinical Oncology · 2021 · 13 citations

Medicine, Oncology, Surgery +17